Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy

PHASE3CompletedINTERVENTIONAL
Enrollment

1,701

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Epilepsy
Interventions
DRUG

Levetiracetam

Daily dose of 1000 to 3000 mg film-coated oral tablets, 250-500 mg twice daily.

DRUG

Carbamazepine Controlled Release (CBZ-CR)

Daily dose of 600-1600 mg CR oral tablets, 200 mg and 400 mg twice daily.

DRUG

Valproate Extended Release

Daily dose of 1000-2000 mg ER oral tablets, 300 mg and 500 mg twice daily.

Trial Locations (229)

Unknown

Adelaide

Bedford Park

Brisbane

Cairns

Camperdown

Chatswood

Clayton

Maroochydore

Parkville

Perth

Randwick

West Heidelberg

Graz

Innsbrick

Klagenfurt

Linz

Steyr

Vienna

Bruges

Dendermonde

Edegem

Ghent

Haine-Saint-Paul

Jette

Kortrijk

Leuven

Ostend

Ottignies

Plovdiv

Sofia

Varna

Litomyšl

Ostrava-Poruba

Zlín

Aalborg

Copenhagen

Holbæk

Holstebro

Hus (Helsinki)

Kuopio

Tampere

Blaye

Bordeaux

Brest

Carcassonne

Cherbourg

Colmar

Creil

Dijon

Freyming-Merlebach

Grenoble

La Seyne-sur-Mer

Lille

Lyon

Marseille

Mulhouse

Nancy

Nîmes

Paris

Rennes

Roanne

Saint-Brieuc

Saint-Quentin

Toulouse

Valenciennes

Vesoul

Altenburg

Arnsdorf

Aschaffenburg

Bamberg

Berlin

Bernau

Bernburg

Bielefeld

Bonn

Butzbach

Celle

Dillingen

Dresden

Düsseldorf

Erbach im Odenwald

Essen

Giessen

Göttingen

Halle

Hamburg

Hohenschönhausen

Jena

Königsbrück

Leipzig

Lengerich

Liegau-Augustusbad

Mittweida

Münster

Neukirchen-Vluyn

Neumünster

Oldenburg

Potsdam

Quickborn

Regenburg

Schalmstadt-Treysa

Siegen

Wermsdorf

Aklion

Alexandroupoli

Athens

Pátrai

Thessaloniki

Thessalonikis

Budapest

Debrecen

Pécs

Dublin

Ancona

Asti

Bari

Busto Arsizio

Casarano

Catania

Cremona

Eboli

Faenza

Ferrara

Florence

Foggia

Forlì

Garbagnate

Grosseto

Milan

Napoli

Padua

Perugia

Pescara

Pisa

Potenza

Prato

Ragusa

Reggio Emilia

Roma

Siena

Taranto

Torino

Udine

Verona

Vimercate

Vittoria

Eindhoven

Heerenvegen

Leeuwarden

Maastricht

Nijmegen

Tilburg

Drammen

Fredrikstad

Lillehammer

Molde

Nordbyhagen

Sandvika

Stavanger

Tromsø

Trondheim

Tønsberg

Bydgoszcz

Częstochowa

Gdansk

Kielce

Krakow

Lodz

Lublin

Olsztyn

Poznan

Warsaw

Zgierz

Bucharest

Cluj-Napoca

Craiova

Krasnoyasrk

Moscow

Saint Petersburg

Bratislava

Dolný Kubín

Dubnica nad Váhom

Martin

Žilina

Badalona

Barakaldo Vizcaya

Barcelona

Castellon

Elda

Girona

Leganes (Madrid)

Madrid

Móstoles

Murcia

Santa Cruz de Tenerife

Seville

Terrassa

Valencia

Vigo

Karlstad

Linköping

Motala

Stockholm

Varberg

Bern

Biel

Geneva

Lausanne

Sankt Gallen

Zurich

Adana

Ankara

Bursa

Istanbul

Izmir

Ashford

Bangor

Bristol

Cardiff

Dundee

Leeds

Liverpool

London

Plymouth

Southampton

Stoke-on-Trent

Sunderland

Swindon

Truro

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY